April 25, 2025 C-Path’s Stephenson Featured in BioCentury Article C-Path Vice President of Neurology and Executive Director of Critical Path for Parkinson's (CPP) Consortium...
April 25, 2025 C-Path’s CPAD Database Drives Insights into Alzheimer’s Disease C-Path’s Critical Path for Alzheimer’s Disease (CPAD) Consortium is thrilled to share...
April 25, 2025 Developing digital health technologies for frontotemporal degeneration Frontotemporal degeneration (FTD) is a rare neurodegenerative disease in which patients can present with cognitive, behavioral...
April 25, 2025 Is Tau Approaching a Tipping Point in Alzheimer’s Drug Development? Is tau the new amyloid? Leaders in the Alzheimer’s field have high conviction in tau — both as a target and surrogate ...
April 23, 2025 C-Path Recognizes HIE Awareness Month, Calls for Global Collaboration to Accelerate Neonatal Drug Development TUCSON, Ariz., April 22, 2025 — Critical Path Institute® (C-Path), through its International Neonatal Consortium...
April 17, 2025 RDCA-DAP Webinar: ACE Inhibitors as a Cardioprotective Treatment in Dystrophinopathies ACE inhibitors were the first pharmacological class shown to benefit heart failure treatment...
April 16, 2025 From C-Path’s T1D Consortium: Pilot GUI Launch Webinar This webinar is designed to give an overview of the Pilot Clinical Trial Simulation Tool...
April 14, 2025 C-Path Honors Memory, Legacy of Beloved CP-RND Member and ALS Patient Advocate Layne Oliff Critical Path Institute (C-Path) mourns the loss of one of its ALS community members, Layne Oliff. Layne, who passed...
April 11, 2025 C-Path Launches Newest Podcast Episode: Connecting the Dots Between T1D and Parkinson’s In our latest episode of the C-Path podcast, “Connecting the Dots Between Type 1 Diabetes and Parkinson’s Disease,” we...
April 11, 2025 2025 Clinical Outcome Assessment Program Annual Meeting Recap On April 9-10, 2025, the 2025 Clinical Outcome Assessment...
